Bob Martin Clear Wormer 500 mg Film Coated Tablets for Dogs.

Land: Irland

Sprache: Englisch

Quelle: HPRA (Health Products Regulatory Authority)

Wirkstoff:

Nitroscanate

Verfügbar ab:

The Bob Martin Company

ATC-Code:

QP52AX01

INN (Internationale Bezeichnung):

Nitroscanate

Dosierung:

500 mg/tablet

Darreichungsform:

Coated tablet

Verschreibungstyp:

CAM: Companion Animal Medicine as defined in relevant national legislation

Therapiegruppe:

Dogs

Therapiebereich:

nitroscanate

Anwendungsgebiete:

Endoparasiticide

Berechtigungsstatus:

Authorised

Berechtigungsdatum:

1995-07-10

Fachinformation

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bob Martin Clear Wormer 500 mg Film Coated Tablets for Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated Tablet.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is a broad spectrum anthelmintic for use in puppies and
adult dogs for the treatment of infection by adult
intestinal nematodes or cestodes of the following species:
Nematodes:
_Toxocara caninum, Toxascaris leonina, Ancylostoma caninum, Uncinaria
stenocephala_
Cestodes:
_Taenia hydatigena, Taenia pisiformis_, and_ Dipylidium caninum_.
4.3 CONTRAINDICATIONS
Do not administer to sick or convalescing animals.
Do not use in puppies of less than 3 weeks of age.
Do not use in
cases of hepatic dysfunction.
Do not use in cases of known hypersensitivity to the active substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product is not indicated for the treatment of_ Trichuris vulpis_
and gives only a limited level of control of
_Echinococcus granulosus._
Since the most common tapeworm of the dog (_Dipylidium caninum_) is
transmitted by a flea and has a very short pre-
patent period, it is important to pay attention to flea control to
reduce the incidence of tapeworm in your pet.
Each tablet contains:
ACTIVE SUBSTANCE;
QUANTITY:
Nitroscanate
500
mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_9_
_/_